COGNITION THERAPEUTICS INC (CGTX:NASDAQ)

$1.22 0.02 (1.6667%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 67

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed COGNITION THERAPEUTICS INC (CGTX:NASDAQ) News Sources

Cognition Therapeutics to Present at Needham Virtual Healthcare Conference

07-04-2026

yahoo.com

external link

Cognition Therapeutics Targets Faster DLB Psychosis Path as Zervimesine Nears Late-Stage Plans

13-04-2026

marketbeat.com

external link

NanoViricides’ Measles Treatment Granted Orphan Drug Designation by FDA

06-05-2026

yahoo.com

external link

NanoViricides to Participate at D. Boral Capital Global Conference in NYC

07-05-2026

yahoo.com

external link

Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update

07-05-2026

yahoo.com

external link

Hantavirus Outbreak Shows Need for Broad-Spectrum Antiviral Drugs

12-05-2026

yahoo.com

external link

Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

14-05-2026

yahoo.com

external link

Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis

21-05-2026

yahoo.com

external link

Cognition Therapeutics Participating in Upcoming Investor Conferences

01-06-2026

yahoo.com

external link

Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies?

02-06-2026

yahoo.com

external link

COGNITION THERAPEUTICS INC (CGTX:NASDAQ) Sentiment Trend

0 25 50 75 100 74 89 56 70 79 8 61 63 83 89 07-04-2026 13-04-2026 06-05-2026 07-05-2026 12-05-2026 14-05-2026 21-05-2026 01-06-2026 02-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

COGNITION THERAPEUTICS INC (CGTX:NASDAQ) FAQs

toggle

What is the current price of COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?

The current price of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is $1.22.


toggle

COGNITION THERAPEUTICS INC (CGTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) since the previous trading day is $0.02.


toggle

COGNITION THERAPEUTICS INC (CGTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) since the previous trading day is 1.6667%.


toggle

What is the most recent average sentiment score for COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?

The most recent average sentiment score for COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is 67 out of 100.


toggle

What is the most recent average sentiment for COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?

The most recent sentiment for COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is .


SEC-8K** Filing Available For COGNITION THERAPEUTICS INC (CGTX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

TGTX (Tg Therapeutics)
CNTX (Context Therapeutics Inc)
BCTXZ (Briacell Therapeutics Corp. WT)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.